In a placebo-controlled mid-stage study, Ventyx Biosciences’ oral NLRP3 inhibitor led to rapid and sustained reductions in levels of a protein that’s an indicator of cardiovascular disease risk. The brain-penetrating properties of this once-daily pill also have potential applications addressing inflammation that drives neurodegenerative disorders. The post Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set…
[Sponsored] A webinar sponsored by Verato and scheduled for June 17 from 1 pm to 2 pm ET will explore how a unified identity strategy, spanning patients, providers, and emerging solutions enabling accurate attribution, strengthens interoperability, and ultimately drives VBC success. Register today! The post The Identity Gap Undermining Value-Based Care appeared first on MedCity News.
Valora Therapeutics’ antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup’s science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry. The post Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease,…
By DAVID INTROCASO The Problem From an anthropocentric perspective, the climate crisis is fundamentally a threat to human health and survival. The US healthcare industry significantly contributes to this threat. US healthcare’s greenhouse gas emissions (GHG) annually account for over 600 million metric tons of carbon dioxide equivalents or ~10% of total US annual GHG…
That is the title of a recent paper by Gao, Kim, and Sevilir (2025). The authors examine 1218 hospital merger and acquisition (M&A) deals in the hospital industry between 2001 and 2008. The authors focus solely on M&A deals with for-profit entities as they argue that they want to examine whether private equity (PE) specifically…
SAN FRANCISCO — For years, Latinos represented the biggest share of new HIV cases in this city, but testing data suggests the tide may be turning. The number of Latinos newly testing positive for HIV dropped 46% from 2022 to 2023, according to a preliminary report released in July by the San Francisco Department of…
Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more. The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.
New service includes a direct line to a real human assistant to curate appointments, plus 24/7 virtual urgent care access nationwide
ERWIN, Tenn. — April Boyd texted her husband before she boarded the helicopter. “So, I don’t want to be dramatic,” she wrote on Sept. 27, “but we are gonna fly and rescue patients from the rooftop of Unicoi hospital.” Earlier that day, Hurricane Helene roared into the Southern Appalachian Mountains after moving north through Florida…
Listen: More than 2 million Americans could benefit from PrEP, but only about a quarter of them are getting the HIV prevention medication. On Feb. 4, during WAMU’s “Health Hub,” KFF Health News reporter Zach Dyer shared tips for overcoming common hurdles to care. Billing mistakes. Stigma. Doctors who aren’t keeping up with the latest…